DanielaAnnenelieBotaMDPhD
Neurology • Costa Mesa, CANeurooncology
Vice Dean, Clinical Research Director, Alpha Clinic Professor, Neurology, University of California, Irvine School of Medicine
Dr. Bota is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1640 Newport Blvd
Ste 400
Costa Mesa, CA 92627Phone+1 949-999-2400Fax+1 949-999-2405- Is this information wrong?
Summary
- Dr. Daniela Bota is a Neurological Oncologist in Irvine, CA and is affiliated with UCI Medical Center. She received her medical degree from Carol Davila University of Medicine and Pharmacy and has been in practice 20 years. She specializes in neurooncology and is experienced in neuro-oncology, gliomas, primary brain tumors, and antineoplastic agents.
Education & Training
Duke University HospitalFellowship, Neurologic Oncology, 2006 - 2007
University of Kansas School of MedicineResidency, Neurology, 2003 - 2006
Carol Davila University of Medicine and PharmacyClass of 1997
Certifications & Licensure
CA State Medical License 2007 - 2025
NC State Medical License 2006 - 2008- American Board of Psychiatry and Neurology Neurology
- AOA Board of Neurology and Psychiatry Neurology
Clinical Trials
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01
- Neurological Surgery & Affiliated Services De-Identified Clinical Outcomes Database Start of enrollment: 2005 Aug 04
- Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Marizomib for patients with newly diagnosed glioblastoma: a randomized phase 3 trial.Patrick Roth, Thierry Gorlia, Jaap C Reijneveld, Filip de Vos, Ahmed Idbaih, Jean-Sébastien Frenel, Emilie Le Rhun, Juan Manuel Sepulveda, James Perry, G Laura Masucci...> ;Neuro-Oncology. 2024 Mar 19
- Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma.Zahra Motahari, Javier J Lepe, Malia R Bautista, Bhaskar Das, Christie D Fowler, Clay Hoerig, Ashley S Plant-Fox, Suresh N Magge, Daniela A Bota> ;Biorxiv. 2024 Mar 3
- Cisplatin induces BDNF downregulation in middle-aged female rat model while BDNF enhancement attenuates cisplatin neurotoxicity.Pearre, D. C., Naomi Lomeli, Diana C Pearre, Maureen Cruz, Kaijun Di, Joni L Ricks-Oddie, Daniela A Bota> ;Experimental Neurology. 2024 May 1
- Join now to see all
Press Mentions
With Award of $8 Million, UC Irvine and Regional Partners Will Expand Stem Cell TreatmentsOctober 31st, 2022- UCI Earns Designation as CIRM Alpha Clinic with Five-Year, $8 Million GrantOctober 27th, 2022
- ERC Announces Publication of Positive Efficacy Data with Sitoiganap in Patients with Recurrent GlioblastomaJune 30th, 2022
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
UCI HealthOrange, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
